The ACE Inhibitors Market: Steady Growth Driven by Rising Cardiovascular Disease Burden
The global Angiotensin Converting Enzyme (ACE) inhibitors market continues to demonstrate resilient growth, reflecting the increasing prevalence of cardiovascular diseases and hypertension worldwide. As one of the most established classes of antihypertensive medications, ACE inhibitors have become cornerstone treatments for managing high blood pressure, heart failure, and diabetic nephropathy. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=10920&type=requestsample Market Size and Growth Projections The global market for Angiotensin Converting Enzyme (ACE) Inhibitors was estimated at US$2.8 Billion in 2023 and is projected to reach US$3.5 Billion by 2030, growing at a CAGR of 3.7% from 2023 to 2030. However, market projections vary across research firms, with some analysts forecasting more robust growth. The global ACE ihibitors market size was valued at USD 6.70 Billion in 2023 and it is expected to grow to USD 9.78 Billion by 2031 with a CAGR of ...